Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 0.36 |
| ▸ | ABHD5 | Q8WTS1 | 1/20 | 0.36 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21674201 | 0.86 | CYP3A4 (0.40) | KDM4EGABRA1GABRB2LMNAMAPT | |
| SCHEMBL8515208 | 0.84 | TP53 (0.44) | KDM4EGABRA1GABRB2TP53LMNA | |
| SCHEMBL29141696 | 0.76 | GABRA1 (0.39) | GABRA1GABRB2LMNAMAPTCYP2C19 | |
| SCHEMBL16958549 | 0.76 | GABRA1 (0.46) | GABRA1GABRB2MAPTHTTCLCN2 | |
| SCHEMBL2346090 | 0.76 | GABRA1 (0.41) | KDM4EGABRA1GABRB2TP53LMNA | |
| SCHEMBL547944 | 0.74 | MEN1 (0.44) | GABRA1GABRB2LMNAHTTMEN1 | |
| Acetic Acid SCHEMBL3669685 | 0.73 | GABRA1 (0.52) | GABRA1GABRB2CYP2C19HTTCLCN2 | |
| SCHEMBL20548408 | 0.72 | ALDH1A1 (0.38) | KDM4ELMNAHTTCYP3A4L3MBTL1 | |
| SCHEMBL16287426 | 0.72 | TP53 (0.56) | KDM4ETP53CYP2C19HTTCYP3A4 | |
| SCHEMBL59712 | 0.72 | GABRA1 (0.41) | GABRA1GABRB2LMNAL3MBTL1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260014066-A1 | Silk-Based Moisturizer Compositions and Methods Thereof | EVOLVED BY NATURE INC (US) | 2026-01-15 | — | — | US | claimed |
| US-11878070-B2 | Silk-based moisturizer compositions and methods thereof | EVOLVED BY NATURE, INC. (US) | 2024-01-23 | — | — | US | claimed |
| EP-3288528-A1 | SILK-BASED MOISTURIZER COMPOSITIONS AND METHODS THEREOF | Silk Therapeutics Inc. (US) | 2018-03-07 | — | — | EP | claimed |
| WO-2016176633-A1 | SILK-BASED MOISTURIZER COMPOSITIONS AND METHODS THEREOF | Silk Therapeutics, Inc. (US) | 2016-11-03 | — | — | WO | claimed |
| US-9402793-B2 | Use of UV-filters to stabilize resveratrol in topical cosmetic compositions | DSM IP ASSETS B.V. (NL) | 2016-08-02 | — | — | US | claimed |
| US-20130324616-A1 | USE OF UV-FILTERS TO STABILIZE RESVERATROL IN TOPICAL COSMETIC COMPOSITIONS | DSM IP ASSETS B.V. (NL) | 2013-12-05 | — | — | US | claimed |
| US-20130315848-A1 | COSMETIC COMPOSITION FOR SKIN WHITENING COMPRISING RESVERATROL | DSM IP ASSETS B.V. (NL) | 2013-11-28 | — | — | US | claimed |
| EP-2642973-A1 | COSMETIC COMPOSITION FOR SKIN WHITENING COMPRISING RESVERATROL | DSM IP Assets B.V. (NL) | 2013-10-02 | — | — | EP | claimed |
| WO-2012069362-A1 | COSMETIC COMPOSITION FOR SKIN WHITENING COMPRISING RESVERATROL | DSM IP ASSETS B.V. (NL) | 2012-05-31 | — | — | WO | claimed |
| WO-2004062635-A1 | COMPOSITIONS FOR SKIN LIGHTENING COMPRISING BIS-PANTOYL-CYSTAMINE | DSM IP ASSETS B.V. (NL) | 2004-07-29 | — | — | WO | claimed |
| US-20260137613-A1 | MANUFACTURE, ISOLATION, PURIFICATION, AND USES OF SMALL PARTICLE SIZE CELLULOSE PARTICLES AND COMPOSITIONS | RENMATIX INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-20260068887-A1 | XANTHENE DYE COMBINATIONS FOR ENHANCED BACTERIAL, YEAST, AND FUNGAL MICROBIAL CONTROL | ICHOR MICROBIAL SOLUTIONS INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-12558303-B2 | Manufacture, isolation, purification, and uses of small particle size cellulose particles and compositions | RENMATIX, INC. (US) | 2026-02-24 | — | — | US | disclosed |
| US-20260014066-A1 | Silk-Based Moisturizer Compositions and Methods Thereof | EVOLVED BY NATURE INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12447122-B2 | Silk-based moisturizer compositions and methods thereof | EVOLVED BY NATURE, INC. (US) | 2025-10-21 | — | — | US | disclosed |
| WO-2000023044-A1 | UV PROTECTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-04-27 | — | — | WO | disclosed |
| EP-0736070-B1 | PROCESS FOR MAKING A NON-AQUEOUS DISPERSION OF A COOPER PHTHALOCYANINE | ZENECA LTD (GB) | 1999-02-24 | — | — | EP | disclosed |
| US-5753022-A | FOR PREPARING NONAQUEOUS DISPERSION OF COPPER PHTHALOCYANINE BY MILLING IN A HIGH BOILING LIQUID IN THE PRESENCE OF A POLYESTER AMINE OR POLYESTERAMMONIUM SALT SALT AND A FLUIDIZING AGENT | ZENECA LIMITED (GB) | 1998-05-19 | — | — | US | disclosed |
| EP-0736070-A1 | PROCESS FOR MAKING A NON-AQUEOUS DISPERSION OF A COOPER PHTHALOCYANINE | ZENECA LIMITED (GB) | 1996-10-09 | — | — | EP | disclosed |
| WO-1995017473-A1 | PROCESS FOR MAKING A NON-AQUEOUS DISPERSION OF A COOPER PHTHALOCYANINE | ZENECA LIMITED (GB) | 1995-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260068887-A1 | XANTHENE DYE COMBINATIONS FOR ENHANCED BACTERIAL, YEAST, AND FUNGAL MICROBIAL CONTROL | TYR, PPOX, TH | KDM4E 581/4885GABRA1 4743/4885GABRB2 4304/4885 |
| US-20260014066-A1 | Silk-Based Moisturizer Compositions and Methods Thereof | CUTA, CD44, F12 | KDM4E 3212/4885GABRA1 4096/4885GABRB2 4446/4885 |
| US-12558303-B2 | Manufacture, isolation, purification, and uses of small particle size cellulose particles and compositions | CUTA, COL2A1, SAMM50 | KDM4E 884/4885GABRA1 4488/4885GABRB2 4645/4885 |
| US-20260137613-A1 | MANUFACTURE, ISOLATION, PURIFICATION, AND USES OF SMALL PARTICLE SIZE CELLULOSE PARTICLES AND COMPOSITIONS | CUTA, COL2A1, COL1A1 | KDM4E 536/4885GABRA1 4592/4885GABRB2 4676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.